Erdafitinib can cause adverse reactions affecting the eyes, mouth, skin, nails, gastrointestinal system and laboratory parameters. The likelihood and severity vary among patients.
Commonly reported adverse reactions
Current prescribing information identifies adverse reactions including:
- Hyperphosphatemia
- Diarrhea
- Stomatitis
- Dry mouth
- Nail disorders
- Palmar-plantar erythrodysesthesia syndrome
- Decreased appetite
- Taste disturbance
- Dry skin
- Alopecia
- Constipation
- Increased liver enzymes
- Eye disorders
Important adverse effects
| Adverse effect | Why it matters |
|---|---|
| Hyperphosphatemia | May require monitoring and treatment adjustment |
| Ocular toxicity | Can affect vision and retinal structures |
| Retinal pigment epithelial detachment | Requires ophthalmic evaluation and management |
| Stomatitis | Mouth inflammation can interfere with eating and comfort |
| Nail disorders | Nail-bed and nail-plate changes can develop |
| Palmar-plantar erythrodysesthesia | Can cause discomfort involving hands and feet |
| Diarrhea | Can become clinically significant |
| Dry mouth | May contribute to oral discomfort |
| Skin effects | Can include dryness and other dermatologic reactions |
Ocular toxicity
Erdafitinib can cause central serous retinopathy or retinal pigment epithelial detachment. Visual symptoms should be reported promptly rather than monitored at home without professional assessment.
Hyperphosphatemia
FGFR inhibition can increase serum phosphate. This effect is clinically relevant to dosing because phosphate measurements are used when deciding whether to increase the starting dose.
Nail and skin effects
Nail dystrophy, onycholysis and hand-foot syndrome are recognized treatment-related problems. These effects may require supportive care or dose modification depending on severity.
When urgent medical assessment may be needed
Prompt medical attention is appropriate for significant visual changes, severe eye pain, sudden vision loss, severe weakness, severe diarrhea, serious skin reactions, difficulty swallowing, severe mouth inflammation or other symptoms that may represent significant toxicity.